InvestorsHub Logo
Followers 58
Posts 10258
Boards Moderated 1
Alias Born 09/21/2016

Re: Rubyred77 post# 180728

Thursday, 02/07/2019 5:09:45 PM

Thursday, February 07, 2019 5:09:45 PM

Post# of 467735
Was his comment on expiry about using up existing inventory? I would have guessed all that would be considered when trial planning was done. Build/produce enough for trials w/some contingency build. Building additional beyond normal planning will actually expose more inventory to expiration if unused. (we do not know any shelf life issues exist) So anyways, why does a company in clinical trials need to build up product inventory? Good question Biostockclub. My guess is follow more crumbs for the trail.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News